UPDATE: Wedbush Downgrades MAP Pharma (MAPP) to Neutral, Notes Other Potential M&A Targets
Tweet Send to a Friend
(Updated - March 1, 2013 1:58 PM EST)
Wedbush downgraded MAP Pharmaceuticals (NASDAQ: MAPP) from Outperform to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush downgraded MAP Pharmaceuticals (NASDAQ: MAPP) from Outperform to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
